Genertec Universal Medical Group Company Limited
HKEX:2666.HK
5.06 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 6,411.22 | 6,898.063 | 6,520.987 | 6,169.485 | 5,560.903 | 4,744.137 | 4,822.769 | 4,351.995 | 3,891.239 | 3,552.492 | 3,194.32 | 2,200.301 | 2,094.712 | 1,770.6 | 1,653.38 | 1,457.443 | 1,251.272 | 1,213.151 | 982.051 | 883.781 | 672.98 | 388.171 |
Cost of Revenue
| 0 | -45.073 | 0 | 164.579 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 221.213 | 154.899 | 154.899 |
Gross Profit
| 6,411.22 | 6,943.136 | 6,520.987 | 6,004.906 | 5,560.903 | 4,744.137 | 4,822.769 | 4,351.995 | 3,891.239 | 3,552.492 | 3,194.32 | 2,200.301 | 2,094.712 | 1,770.6 | 1,653.38 | 1,457.443 | 1,251.272 | 1,213.151 | 982.051 | 662.568 | 518.082 | 233.272 |
Gross Profit Ratio
| 1 | 1.007 | 1 | 0.973 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.75 | 0.77 | 0.601 |
Reseach & Development Expenses
| 16.422 | 29.023 | 6.852 | 41.764 | 6.309 | 18.412 | 7.432 | 8.123 | 8.506 | 13.825 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 616.155 | 630.17 | 538.266 | 473.311 | 440.686 | 359.738 | 380.016 | 357.404 | 256.464 | 258.842 | 182.566 | 135.898 | 108.452 | 74.233 | 115.387 | 158.207 | 119.025 | 144.872 | 101.624 | 118.42 | 72.194 | 47.654 |
Selling & Marketing Expenses
| 181.116 | 237.395 | 159.773 | 215.81 | 225.793 | 201.325 | 260.68 | 199.861 | 180.529 | 232.124 | 172.465 | 216.035 | 171.216 | 176.287 | 157.916 | 156.76 | 120.491 | 140.901 | 73.025 | 73.218 | 53.077 | 31.574 |
SG&A
| 797.271 | 867.565 | 698.039 | 689.121 | 666.479 | 561.063 | 640.696 | 557.265 | 436.993 | 490.966 | 355.031 | 351.933 | 279.668 | 250.52 | 273.303 | 314.967 | 239.516 | 285.773 | 174.649 | 184.624 | 132.285 | 79.227 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.1 | -1.189 | -1.189 |
Operating Expenses
| 813.693 | 896.588 | 4,957.492 | 4,971.013 | 4,056.101 | 3,527.843 | 3,347.255 | 3,115.174 | 2,763.046 | 2,534.648 | 2,000.305 | 1,342.921 | 1,093.053 | 994.047 | 853.472 | 798.345 | 704.425 | 680.626 | 614.302 | 508.799 | 436.88 | 78.038 |
Operating Income
| 5,597.527 | 6,001.475 | 1,452.673 | 1,233.084 | 1,562.826 | 1,112.152 | 1,538.161 | 1,137.831 | 1,143.882 | 975.387 | 1,288.923 | 910.733 | 1,047.237 | 849.735 | 805.782 | 641.862 | 546.4 | 483.739 | 366.19 | 356.125 | 264.133 | 152.771 |
Operating Income Ratio
| 0.873 | 0.87 | 0.223 | 0.2 | 0.281 | 0.234 | 0.319 | 0.261 | 0.294 | 0.275 | 0.404 | 0.414 | 0.5 | 0.48 | 0.487 | 0.44 | 0.437 | 0.399 | 0.373 | 0.403 | 0.392 | 0.394 |
Total Other Income Expenses Net
| -3,978.853 | -4,698.757 | 110.822 | -34.612 | -58.024 | 104.142 | -62.647 | 98.99 | -15.689 | 42.457 | -94.908 | -53.353 | -45.578 | -73.182 | -5.874 | 17.236 | 0.447 | 48.786 | 1.559 | 18.857 | -28.033 | 0 |
Income Before Tax
| 1,618.674 | 1,302.718 | 1,563.495 | 1,198.472 | 1,504.802 | 1,216.294 | 1,475.514 | 1,236.821 | 1,128.193 | 1,017.844 | 1,194.015 | 857.38 | 1,001.659 | 776.553 | 799.908 | 659.098 | 546.847 | 532.525 | 367.749 | 374.982 | 236.1 | 152.771 |
Income Before Tax Ratio
| 0.252 | 0.189 | 0.24 | 0.194 | 0.271 | 0.256 | 0.306 | 0.284 | 0.29 | 0.287 | 0.374 | 0.39 | 0.478 | 0.439 | 0.484 | 0.452 | 0.437 | 0.439 | 0.374 | 0.424 | 0.351 | 0.394 |
Income Tax Expense
| 366.501 | 297.228 | 369.913 | 288.884 | 328.442 | 311.348 | 349.991 | 283.889 | 267.215 | 255.977 | 321.49 | 239.969 | 268.406 | 206.789 | 220.993 | 176.333 | 157.302 | 143.913 | 97.835 | 93.839 | 60.605 | 38.611 |
Net Income
| 1,172.964 | 974.369 | 1,093.175 | 799.052 | 1,089.365 | 785.277 | 1,049.956 | 854.135 | 793.402 | 676.751 | 811.985 | 616.641 | 735.532 | 569.705 | 578.953 | 482.765 | 389.545 | 388.612 | 269.914 | 281.143 | 175.495 | 114.16 |
Net Income Ratio
| 0.183 | 0.141 | 0.168 | 0.13 | 0.196 | 0.166 | 0.218 | 0.196 | 0.204 | 0.191 | 0.254 | 0.28 | 0.351 | 0.322 | 0.35 | 0.331 | 0.311 | 0.32 | 0.275 | 0.318 | 0.261 | 0.294 |
EPS
| 0.57 | 0.46 | 0.53 | 0.39 | 0.53 | 0.39 | 0.53 | 0.5 | 0.46 | 0.39 | 0.47 | 0.36 | 0.43 | 0.33 | 0.34 | 0.28 | 0.23 | 0.23 | 0.21 | 0.28 | 0.22 | 0.09 |
EPS Diluted
| 0.58 | 0.47 | 0.52 | 0.38 | 0.53 | 0.38 | 0.52 | 0.5 | 0.46 | 0.39 | 0.47 | 0.36 | 0.43 | 0.33 | 0.34 | 0.28 | 0.23 | 0.23 | 0.21 | 0.28 | 0.22 | 0.09 |
EBITDA
| 5,518.318 | -97.458 | 10.415 | -145.148 | -145.019 | -15.527 | -138.214 | 0.193 | -83.265 | -42.659 | -155.448 | -54.123 | -43.299 | -73.241 | -5.836 | 17.236 | 0.447 | 48.786 | 1.559 | 18.857 | -28.033 | 156.558 |
EBITDA Ratio
| 0.861 | -0.014 | 0.002 | -0.024 | -0.026 | -0.003 | -0.029 | 0 | -0.021 | -0.012 | -0.049 | -0.025 | -0.021 | -0.041 | -0.004 | 0.012 | 0 | 0.04 | 0.002 | 0.021 | -0.042 | 0.403 |